Perioperative inhibition of β-adrenergic and COX2 signaling in a clinical trial in breast cancer patients improves tumor Ki-67 expression, serum cytokine levels, and PBMCs transcriptome

Aigner, 2007, The transcription factor ZEB1 (deltaEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity, Oncogene, 26, 6979, 10.1038/sj.onc.1210508

Akira, 1990, Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF), FASEB J., 4, 2860, 10.1096/fasebj.4.11.2199284

Albuquerque, 1995, Pre-treatment serum levels of tumour markers in metastatic breast cancer: a prospective assessment of their role in predicting response to therapy and survival, Eur. J. Surg. Oncol., 21, 504, 10.1016/S0748-7983(95)96935-7

Andersen, 1998, Stress and immune responses after surgical treatment for regional breast cancer, J. Natl. Cancer Inst., 90, 30, 10.1093/jnci/90.1.30

Arany, 1996, An essential role for p300/CBP in the cellular response to hypoxia, Proc. Natl. Acad. Sci. U.S.A., 93, 12969, 10.1073/pnas.93.23.12969

Avalle, 2012, STAT1 and STAT3 in tumorigenesis: a matter of balance, JAKSTAT, 1, 65

Bach, 1997, The IFN gamma receptor: a paradigm for cytokine receptor signaling, Annu. Rev. Immunol., 15, 563, 10.1146/annurev.immunol.15.1.563

Balzarolo, 2013, NAB2 and EGR-1 exert opposite roles in regulating TRAIL expression in human Natural Killer cells, Immunol. Lett., 151, 61, 10.1016/j.imlet.2013.02.001

Bartal, 2010, Immune perturbations in patients along the perioperative period: alterations in cell surface markers and leukocyte subtypes before and after surgery, Brain Behav. Immun., 24, 376, 10.1016/j.bbi.2009.02.010

Baumann, 1994, The acute phase response, Immunol. Today, 15, 74, 10.1016/0167-5699(94)90137-6

Beissbarth, 2004, GOstat: find statistically overrepresented Gene Ontologies within a group of genes, Bioinformatics, 20, 1464, 10.1093/bioinformatics/bth088

Ben-Eliyahu, 2000, Suppression of NK cell activity and of resistance to metastasis by stress: a role for adrenal catecholamines and beta-adrenoceptors, Neuroimmunomodulation, 8, 154, 10.1159/000054276

Benish, 2008, Perioperative use of beta-blockers and COX-2 inhibitors may improve immune competence and reduce the risk of tumor metastasis, Ann. Surg. Oncol., 15, 2042, 10.1245/s10434-008-9890-5

Benoy, 2002, Serum interleukin 6, plasma VEGF, serum VEGF, and VEGF platelet load in breast cancer patients, Clin. Breast Cancer, 2, 311, 10.3816/CBC.2002.n.008

Benoy, 2004, Increased serum interleukin-8 in patients with early and metastatic breast cancer correlates with early dissemination and survival, Clin. Cancer Res., 10, 7157, 10.1158/1078-0432.CCR-04-0812

Bisgin, 2012, Increased serum sTRAIL levels were correlated with survival in bevacizumab-treated metastatic colon cancer, BMC Cancer, 12, 58, 10.1186/1471-2407-12-58

Bluyssen, 2010, IFN gamma-dependent SOCS3 expression inhibits IL-6-induced STAT3 phosphorylation and differentially affects IL-6 mediated transcriptional responses in endothelial cells, Am. J. Physiol. Cell Physiol., 299, C354, 10.1152/ajpcell.00513.2009

Bolstad, 2003, A comparison of normalization methods for high density oligonucleotide array data based on variance and bias, Bioinformatics, 19, 185, 10.1093/bioinformatics/19.2.185

Bozinovski, 2016, COPD and squamous cell lung cancer: aberrant inflammation and immunity is the common link, Brit. J. Pharmacol., 173, 635, 10.1111/bph.13198

Buvanendran, 2006, Upregulation of prostaglandin E2 and interleukins in the central nervous system and peripheral tissue during and after surgery in humans, Anesthesiology, 104, 403, 10.1097/00000542-200603000-00005

Calcagni, 2006, Stress system activity, innate and T helper cytokines, and susceptibility to immune-related diseases, Ann. N. Y. Acad. Sci., 1069, 62, 10.1196/annals.1351.006

Cole, 2010, Elevating the perspective on human stress genomics, Psychoneuroendocrinology, 35, 955, 10.1016/j.psyneuen.2010.06.008

Cole, 2007, Social regulation of gene expression in human leukocytes, Genome Biol., 8, R189, 10.1186/gb-2007-8-9-r189

Cole, 2010, Computational identification of gene-social environment interaction at the human IL6 locus, Proc. Natl. Acad. Sci. U.S.A., 107, 5681, 10.1073/pnas.0911515107

Cole, 2015, Sympathetic nervous system regulation of the tumour microenvironment, Nat. Rev. Cancer, 15, 563, 10.1038/nrc3978

Cole, 2012, Molecular pathways: beta-adrenergic signaling in cancer, Clin. Cancer Res., 18, 1201, 10.1158/1078-0432.CCR-11-0641

Cole, 2005, Expression-based monitoring of transcription factor activity: the TELiS database, Bioinformatics, 21, 803, 10.1093/bioinformatics/bti038

Culver, 2002, Coping and distress among women under treatment for early stage breast cancer: comparing African Americans, Hispanics and non-Hispanic Whites, Psychooncology, 11, 495, 10.1002/pon.615

Dalton, 2017, Macrophages facilitate resistance to anti-VEGF therapy by altered VEGFR expression, Clin. Cancer Res., 23, 7034, 10.1158/1078-0432.CCR-17-0647

de Nigris, 2010, CXCR4/YY1 inhibition impairs VEGF network and angiogenesis during malignancy, Proc. Natl. Acad. Sci. U.S.A., 107, 14484, 10.1073/pnas.1008256107

Diehl, 2000, Inhibition of Th1 differentiation by IL-6 is mediated by SOCS1, Immunity, 13, 805, 10.1016/S1074-7613(00)00078-9

Diehl, 2002, The two faces of IL-6 on Th1/Th2 differentiation, Mol. Immunol., 39, 531, 10.1016/S0161-5890(02)00210-9

Du, 2012, RORalpha, a potential tumor suppressor and therapeutic target of breast cancer, Int. J. Mol. Sci., 13, 15755, 10.3390/ijms131215755

Eissa, 2005, Importance of serum IL-18 and RANTES as markers for breast carcinoma progression, J. Egypt. Natl. Cancer Inst., 17, 51

Elenkov, 2008, Neurohormonal-cytokine interactions: implications for inflammation, common human diseases and well-being, Neurochem. Int., 52, 40, 10.1016/j.neuint.2007.06.037

Elenkov, 1996, Modulatory effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: clinical implications, Proc. Assoc. Am. Physicians, 108, 374

Elenkov, 2000, The sympathetic nerve–an integrative interface between two supersystems: the brain and the immune system, Pharmacol. Rev., 52, 595

Elenkov, 2005, Cytokine dysregulation, inflammation and well-being, Neuroimmunomodulation, 12, 255, 10.1159/000087104

Esquivel-Velazquez, 2015, The role of cytokines in breast cancer development and progression, J. Interferon Cytokine Res., 35, 1, 10.1089/jir.2014.0026

Glasner, 2010, Improving survival rates in two models of spontaneous postoperative metastasis in mice by combined administration of a beta-adrenergic antagonist and a cyclooxygenase-2 inhibitor, J. Immunol., 184, 2449, 10.4049/jimmunol.0903301

Goodman, 2000, CBP/p300 in cell growth, transformation, and development, Genes Development, 14, 1553, 10.1101/gad.14.13.1553

Gotlieb, 2015, The misleading nature of in vitro and ex vivo findings in studying the impact of stress hormones on NK cell cytotoxicity, Brain Behav. Immun., 45, 277, 10.1016/j.bbi.2014.12.020

Gracie, 2003, Interleukin-18, J. Leukoc. Biol., 73, 213, 10.1189/jlb.0602313

Greenfeld, 2007, Immune suppression while awaiting surgery and following it: dissociations between plasma cytokine levels, their induced production, and NK cell cytotoxicity, Brain Behav. Immun., 21, 503, 10.1016/j.bbi.2006.12.006

Grivennikov, 2010, Immunity, inflammation, and cancer, Cell, 140, 883, 10.1016/j.cell.2010.01.025

Gunawardana, 2013, Bridging the gap between transcriptome and proteome measurements identifies post-translationally regulated genes, Bioinformatics, 29, 3060, 10.1093/bioinformatics/btt537

Haldar, 2017, Perioperative β-adrenergic blockade and COX2 inhibition in colorectal cancer patients improves pro-metastatic indices in the excised tumor: EMT, tumor infiltrating lymphocytes (TILs), and gene regulatory pathways

Hall, 2010, Activation of the aryl-hydrocarbon receptor inhibits invasive and metastatic features of human breast cancer cells and promotes breast cancer cell differentiation, Mol. Endocrinol., 24, 359, 10.1210/me.2009-0346

Heinrich, 2003, Principles of interleukin (IL)-6-type cytokine signalling and its regulation, Biochem. J., 374, 1, 10.1042/bj20030407

Heublein, 2015, Thyroid hormone receptors predict prognosis in BRCA1 associated breast cancer in opposing ways, PLoS One, 10, e0127072, 10.1371/journal.pone.0127072

Hietbrink, 2006, Trauma: the role of the innate immune system, World J. Emerg. Surg., 1, 15, 10.1186/1749-7922-1-15

Hinson, 1996, Elevated interleukin 6 is induced by prostaglandin E2 in a murine model of inflammation: possible role of cyclooxygenase-2, Proc. Natl. Acad. Sci. U.S.A., 93, 4885, 10.1073/pnas.93.10.4885

Holoch, 2009, TNF-related apoptosis-inducing ligand (TRAIL): a new path to anti-cancer therapies, Eur. J. Pharmacol., 625, 63, 10.1016/j.ejphar.2009.06.066

Horowitz, 2015, Exploiting the critical perioperative period to improve long-term cancer outcomes, Nat. Rev. Clin. Oncol., 12, 213, 10.1038/nrclinonc.2014.224

Hurt, 2008, Expression of the ZEB1 (deltaEF1) transcription factor in human: additional insights, Mol. Cell. Biochem., 318, 89, 10.1007/s11010-008-9860-z

Inbar, 2011, Do stress responses promote leukemia progression? An animal study suggesting a role for epinephrine and prostaglandin-E2 through reduced NK activity, PLoS One, 6, e19246, 10.1371/journal.pone.0019246

Ishihara, 2013, Retrospective analysis of risk factors for central nervous system metastases in operable breast cancer: effects of biologic subtype and Ki67 overexpression on survival, Oncology, 84, 135, 10.1159/000345321

Jongeneel, 1995, Transcriptional regulation of the tumor necrosis factor alpha gene, Immunobiology, 193, 210, 10.1016/S0171-2985(11)80545-0

Kalinski, 2012, Regulation of immune responses by prostaglandin E2, J. Immunol., 188, 21, 10.4049/jimmunol.1101029

Kavelaars, 1997, Beta 2-adrenergic activation enhances interleukin-8 production by human monocytes, J. Neuroimmunol., 77, 211, 10.1016/S0165-5728(97)00076-3

Kim, 2003, The role of the cytokine network in psychological stress, Acta Neuropsychiatry, 15, 148, 10.1034/j.1601-5215.2003.00026.x

Kontzoglou, 2013, Correlation between Ki67 and breast cancer prognosis, Oncology, 84, 219, 10.1159/000346475

Kuebler, 2015, Stress-induced modulation of NF-kappaB activation, inflammation-associated gene expression, and cytokine levels in blood of healthy men, Brain Behav. Immun., 46, 87, 10.1016/j.bbi.2014.12.024

Larsson, 2009, The Sp1 transcription factor binds to the G-allele of the -1087 IL-10 gene polymorphism and enhances transcriptional activation, Genes Immun., 10, 280, 10.1038/gene.2008.79

Lee, 2009, Surgical stress promotes tumor growth in ovarian carcinoma, Clin. Cancer Res., 15, 2695, 10.1158/1078-0432.CCR-08-2966

Li, 2015, GATA1 induces epithelial-mesenchymal transition in breast cancer cells through PAK5 oncogenic signaling, Oncotarget, 6, 4345, 10.18632/oncotarget.2999

Li, 2016, c-Myb enhances breast cancer invasion and metastasis through the Wnt/beta-catenin/Axin2 pathway, Cancer Res., 76, 3364, 10.1158/0008-5472.CAN-15-2302

Liu, 2016, Overexpression of MYCN promotes proliferation of non-small cell lung cancer, Tumour Biol., 37, 12855, 10.1007/s13277-016-5236-2

Lutgendorf, 2010, Host factors and cancer progression: biobehavioral signaling pathways and interventions, J. Clin. Oncol., 28, 4094, 10.1200/JCO.2009.26.9357

Magnani, 2015, The pioneer factor PBX1 is a novel driver of metastatic progression in ERalpha-positive breast cancer, Oncotarget, 6, 21878, 10.18632/oncotarget.4243

Mahalingam, 2009, TRAIL receptor signalling and modulation: are we on the right TRAIL?, Cancer Treat. Rev., 35, 280, 10.1016/j.ctrv.2008.11.006

Marshall, 1998, Cytokine dysregulation associated with exam stress in healthy medical students, Brain Behav. Immun., 12, 297, 10.1006/brbi.1998.0537

Melamed, 2005, Marginating pulmonary-NK activity and resistance to experimental tumor metastasis: suppression by surgery and the prophylactic use of a beta-adrenergic antagonist and a prostaglandin synthesis inhibitor, Brain Behav. Immun., 19, 114, 10.1016/j.bbi.2004.07.004

Menger, 2004, Surgical trauma: hyperinflammation versus immunosuppression?, Langenbecks Arch. Surg., 389, 475, 10.1007/s00423-004-0472-0

Mizukami, 1995, N-myc protein expression in human breast carcinoma: prognostic implications, Anticancer Res., 15, 2899

Motomura, 2011, The transcription factor E4BP4 regulates the production of IL-10 and IL-13 in CD4+ T cells, Nat. Immunol., 12, 450, 10.1038/ni.2020

Moyer, 1996, Psychosocial sequelae of breast cancer and its treatment, Ann. Behav. Med., 18, 110, 10.1007/BF02909583

Mundt, 2003, Involvement of TRAIL and its receptors in viral hepatitis, FASEB J., 17, 94, 10.1096/fj.02-0537fje

Muthuswamy, 2017, Epinephrine promotes COX-2-dependent immune suppression in myeloid cells and cancer tissues, Brain Behav. Immun., 62, 78, 10.1016/j.bbi.2017.02.008

Nakanishi, 2001, Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu, Cytokine Growth Factor Rev., 12, 53, 10.1016/S1359-6101(00)00015-0

Naldini, 1995, In vitro cytokine production and T-cell proliferation in patients undergoing cardiopulmonary by-pass, Cytokine, 7, 165, 10.1006/cyto.1995.1022

Naldini, 1999, Interleukin 10 production in patients undergoing cardiopulmonary bypass: evidence of inhibition of Th-1-type responses, Cytokine, 11, 74, 10.1006/cyto.1998.0400

Neeman, 2012, A new approach to reducing postsurgical cancer recurrence: perioperative targeting of catecholamines and prostaglandins, Clin. Cancer Res., 18, 4895, 10.1158/1078-0432.CCR-12-1087

Nilsson, 2007, Stress hormones regulate interleukin-6 expression by human ovarian carcinoma cells through a Src-dependent mechanism, J. Biol. Chem., 282, 29919, 10.1074/jbc.M611539200

Patel, 2011, Control of EVI-1 oncogene expression in metastatic breast cancer cells through microRNA miR-22, Oncogene, 30, 1290, 10.1038/onc.2010.510

Pei, 2012, Analysis of human Ki-67 gene promoter and identification of the Sp1 binding sites for Ki-67 transcription, Tumour Biol., 33, 257, 10.1007/s13277-011-0277-z

Pepys, 2003, C-reactive protein: a critical update, J. Clin. Invest., 111, 1805, 10.1172/JCI200318921

Pierce, 2009, Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients, J. Clin. Oncol., 27, 3437, 10.1200/JCO.2008.18.9068

Pockaj, 2004, Reduced T-cell and dendritic cell function is related to cyclooxygenase-2 overexpression and prostaglandin E2 secretion in patients with breast cancer, Ann. Surg. Oncol., 11, 328, 10.1245/ASO.2004.05.027

Puren, 1998, Interleukin-18 (IFNgamma-inducing factor) induces IL-8 and IL-1beta via TNFalpha production from non-CD14+ human blood mononuclear cells, J. Clin. Invest., 101, 711, 10.1172/JCI1379

Ramer-Quinn, 1997, Activated T helper 1 and T helper 2 cells differentially express the beta-2-adrenergic receptor – a mechanism for selective modulation of T helper 1 cell cytokine production, J. Immunol., 159, 4857, 10.4049/jimmunol.159.10.4857

Ravishankaran, 2011, Clinical significance of preoperative serum interleukin-6 and C-reactive protein level in breast cancer patients, World J. Surg. Oncol., 9, 18, 10.1186/1477-7819-9-18

Roche-Nagle, 2004, Antimetastatic activity of a cyclooxygenase-2 inhibitor, Br. J. Cancer, 91, 359, 10.1038/sj.bjc.6601967

Rosenne, 2014, In vivo suppression of NK cell cytotoxicity by stress and surgery: glucocorticoids have a minor role compared to catecholamines and prostaglandins, Brain Behav. Immun., 37, 207, 10.1016/j.bbi.2013.12.007

Saito, 2014, Aryl hydrocarbon receptor in breast cancer-a newly defined prognostic marker, Horm Cancer, 5, 11, 10.1007/s12672-013-0160-z

Samuel, 2008, Identification of a novel regulatory region in the interleukin-6 gene promoter, Cytokine, 42, 256, 10.1016/j.cyto.2008.02.008

Sanders, 2012, The beta2-adrenergic receptor on T and B lymphocytes: do we understand it yet?, Brain Behav. Immun., 26, 195, 10.1016/j.bbi.2011.08.001

Sansregret, 2011, Cut homeobox 1 causes chromosomal instability by promoting bipolar division after cytokinesis failure, Proc. Natl. Acad. Sci. U.S.A., 108, 1949, 10.1073/pnas.1008403108

Scholzen, 2000, The Ki-67 protein: from the known and the unknown, J. Cell. Physiol., 182, 311, 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9

Secchiero, 2013, C-Reactive protein downregulates TRAIL expression in human peripheral monocytes via an Egr-1-dependent pathway, Clin. Cancer Res., 19, 1949, 10.1158/1078-0432.CCR-12-3027

Semenza, G.L., 2007. Hypoxia-inducible factor 1 (HIF-1) pathway. Science's STKE: signal transduction knowledge environment, cm8.

Shaashua, 2017, Perioperative COX-2 and beta-adrenergic blockade improves metastatic biomarkers in breast cancer patients in a phase-II randomized trial, Clin. Cancer Res., 23, 4651, 10.1158/1078-0432.CCR-17-0152

Shakhar, 1998, In vivo beta-adrenergic stimulation suppresses natural killer activity and compromises resistance to tumor metastasis in rats, J. Immunol., 160, 3251, 10.4049/jimmunol.160.7.3251

Shi, 2010, Interferon-gamma-mediated inhibition of serum response factor-dependent smooth muscle-specific gene expression, J. Biol. Chem., 285, 32415, 10.1074/jbc.M110.164863

Shinnakasu, 2008, Gfi1-mediated stabilization of GATA3 protein is required for Th2 cell differentiation, J. Biol. Chem., 283, 28216, 10.1074/jbc.M804174200

Siegel, 2016, Cancer statistics, 2016, CA Cancer J. Clin., 66, 7, 10.3322/caac.21332

Singh, 2006, Involvement of IL-8 in COX-2-mediated bone metastases from breast cancer, J. Surg. Res., 134, 44, 10.1016/j.jss.2006.03.018

Sloan, 2010, The sympathetic nervous system induces a metastatic switch in primary breast cancer, Cancer Res., 70, 7042, 10.1158/0008-5472.CAN-10-0522

Smyth, 2003, Nature's TRAIL–on a path to cancer immunotherapy, Immunity, 18, 1, 10.1016/S1074-7613(02)00502-2

Sood, 2006, Stress hormone-mediated invasion of ovarian cancer cells, Clin. Cancer Res., 12, 369, 10.1158/1078-0432.CCR-05-1698

Sorski, 2016, Reducing liver metastases of colon cancer in the context of extensive and minor surgeries through beta-adrenoceptors blockade and COX2 inhibition, Brain Behav. Immun., 10.1016/j.bbi.2016.05.017

Steensberg, 2003, IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans, Am. J. Physiol. Endocrinol. Metab., 285, E433, 10.1152/ajpendo.00074.2003

Steptoe, 2007, The effects of acute psychological stress on circulating inflammatory factors in humans: a review and meta-analysis, Brain Behav. Immun., 21, 901, 10.1016/j.bbi.2007.03.011

Stolina, 2000, Specific inhibition of cyclooxygenase 2 restores antitumor reactivity by altering the balance of IL-10 and IL-12 synthesis, J. Immunol., 164, 361, 10.4049/jimmunol.164.1.361

Sugama, 2008, Interleukin-18 and stress, Brain Res. Rev., 58, 85, 10.1016/j.brainresrev.2007.11.003

Suganuma, 2002, Growth suppression of human carcinoma cells by reintroduction of the p300 coactivator, Proc. Natl. Acad. Sci. U.S.A., 99, 13073, 10.1073/pnas.192586699

Takaki, 1994, Immobilization stress may increase plasma interleukin-6 via central and peripheral catecholamines, Neuroimmunomodulation, 1, 335, 10.1159/000097185

Tian, 2011, A critical role of Sp1 transcription factor in regulating the human Ki-67 gene expression, Tumour Biol., 32, 273, 10.1007/s13277-010-0119-4

Traynor, 1981, Endocrine and metabolic changes during surgery: anaesthetic implications, Br. J. Anaesth., 53, 153, 10.1093/bja/53.2.153

Trinchieri, 2012, Cancer and inflammation: an old intuition with rapidly evolving new concepts, Annu. Rev. Immunol., 30, 677, 10.1146/annurev-immunol-020711-075008

Tsigos, 2002, Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress, J. Psychosom. Res., 53, 865, 10.1016/S0022-3999(02)00429-4

Vogel, 2012, Insights into the regulation of protein abundance from proteomic and transcriptomic analyses, Nat. Rev. Genet., 13, 227, 10.1038/nrg3185

Wang, 2012, GATA2 negatively regulates PTEN by preventing nuclear translocation of androgen receptor and by androgen-independent suppression of PTEN transcription in breast cancer, Hum. Mol. Genet., 21, 569, 10.1093/hmg/ddr491

Wen, 2010, The role of the transcription factor CREB in immune function, J. Immunol., 185, 6413, 10.4049/jimmunol.1001829

Wingender, 1996, TRANSFAC: a database on transcription factors and their DNA binding sites, Nucl. Acids Res., 24, 238, 10.1093/nar/24.1.238

Wojtowicz-Praga, 1997, Reversal of tumor-induced immunosuppression: a new approach to cancer therapy, J. Immunother., 20, 165, 10.1097/00002371-199705000-00001

Xiang, 2012, Effects of acute stress-induced immunomodulation on Th1/Th2 cytokine and catecholamine receptor expression in human peripheral blood cells, Neuropsychobiology, 65, 12, 10.1159/000328160

Yagi, 2011, An updated view on transcription factor GATA3-mediated regulation of Th1 and Th2 cell differentiation, Int. Immunol., 23, 415, 10.1093/intimm/dxr029

Yakar, 2003, Prostaglandin e(2) suppresses NK activity in vivo and promotes postoperative tumor metastasis in rats, Ann. Surg. Oncol., 10, 469, 10.1245/ASO.2003.08.017

Yang, 2002, Stress-induced immunomodulation and the implications for health, Int. Immunopharmacol., 2, 315, 10.1016/S1567-5769(01)00182-5

Yang, 2017, Ki67 targeted strategies for cancer therapy, Clin. Transl. Oncol.

Yerushalmi, 2010, Ki67 in breast cancer: prognostic and predictive potential, Lancet Oncol., 11, 174, 10.1016/S1470-2045(09)70262-1

Zhang, 1999, Serum interleukin-6 levels correlate to tumor progression and prognosis in metastatic breast carcinoma, Anticancer Res., 19, 1427

Zhang, 2014, TH1/TH2 cell differentiation and molecular signals, Adv. Exp. Med. Biol., 841, 15, 10.1007/978-94-017-9487-9_2